Literature DB >> 19299694

Cutting edge: Dok-1 and Dok-2 adaptor molecules are regulated by phosphatidylinositol 5-phosphate production in T cells.

Geoffrey Guittard1, Audrey Gérard, Sophie Dupuis-Coronas, Hélène Tronchère, Eva Mortier, Cédric Favre, Daniel Olive, Pascale Zimmermann, Bernard Payrastre, Jacques A Nunès.   

Abstract

Downstream of tyrosine kinase (Dok) proteins Dok-1 and Dok-2 are involved in T cell homeostasis maintenance. Dok protein tyrosine phosphorylation plays a key role in establishing negative feedback loops of T cell signaling. These structurally related adapter molecules contain a pleckstrin homology (PH) domain generally acting as a lipid/protein-interacting module. We show that the presence of this PH domain is necessary for the tyrosine phosphorylation of Dok proteins and their negative functions in T cells. We find that Dok-1/Dok-2 PH domains bind in vitro to the rare phosphoinositide species, phosphatidylinositol 5-phosphate (PtdIns5P). Dok tyrosine phosphorylation correlates with PtdIns5P production in T cells upon TCR triggering. Furthermore, we demonstrate that PtdIns5P increase regulates Dok tyrosine phosphorylation in vivo. Together, our data identify a novel lipid mediator in T cell signaling and suggest that PH-PtdIns5P interactions regulate T cell responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19299694     DOI: 10.4049/jimmunol.0804172

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  A novel HPLC-based approach makes possible the spatial characterization of cellular PtdIns5P and other phosphoinositides.

Authors:  Deborah Sarkes; Lucia E Rameh
Journal:  Biochem J       Date:  2010-05-27       Impact factor: 3.857

2.  Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling.

Authors:  Robin Mihrshahi; Marion H Brown
Journal:  J Immunol       Date:  2010-11-15       Impact factor: 5.422

3.  Oncogenic tyrosine kinases target Dok-1 for ubiquitin-mediated proteasomal degradation to promote cell transformation.

Authors:  Justyna A Janas; Linda Van Aelst
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

4.  Functional dissociation between PIKfyve-synthesized PtdIns5P and PtdIns(3,5)P2 by means of the PIKfyve inhibitor YM201636.

Authors:  Diego Sbrissa; Ognian C Ikonomov; Catherine Filios; Khortnal Delvecchio; Assia Shisheva
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-23       Impact factor: 4.249

5.  Mutational analysis of the DOK2 haploinsufficient tumor suppressor gene in chronic myelomonocytic leukemia (CMML).

Authors:  E Coppin; V Gelsi-Boyer; X Morelli; N Cervera; A Murati; P P Pandolfi; D Birnbaum; J A Nunès
Journal:  Leukemia       Date:  2014-09-25       Impact factor: 11.528

6.  Feedback circuits monitor and adjust basal Lck-dependent events in T cell receptor signaling.

Authors:  Jamie R Schoenborn; Ying Xim Tan; Chao Zhang; Kevan M Shokat; Arthur Weiss
Journal:  Sci Signal       Date:  2011-09-13       Impact factor: 8.192

Review 7.  The role of phosphoinositides in synapse function.

Authors:  Yoshibumi Ueda
Journal:  Mol Neurobiol       Date:  2014-06-17       Impact factor: 5.590

8.  Production of phosphatidylinositol 5-phosphate via PIKfyve and MTMR3 regulates cell migration.

Authors:  Angela Oppelt; Viola H Lobert; Kaisa Haglund; Ashley M Mackey; Lucia E Rameh; Knut Liestøl; Kay Oliver Schink; Nina Marie Pedersen; Eva M Wenzel; Ellen M Haugsten; Andreas Brech; Tor Erik Rusten; Harald Stenmark; Jørgen Wesche
Journal:  EMBO Rep       Date:  2012-11-16       Impact factor: 8.807

9.  Dok1 and Dok2 proteins regulate natural killer cell development and function.

Authors:  Javier Celis-Gutierrez; Marilyn Boyron; Thierry Walzer; Pier Paolo Pandolfi; Stipan Jonjić; Daniel Olive; Marc Dalod; Eric Vivier; Jacques A Nunès
Journal:  EMBO J       Date:  2014-06-24       Impact factor: 11.598

Review 10.  Localization, regulation and function of type II phosphatidylinositol 5-phosphate 4-kinases.

Authors:  Jonathan H Clarke; Michael Wang; Robin F Irvine
Journal:  Adv Enzyme Regul       Date:  2009-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.